Study reveals 13 key biomarkers, including NT-proBNP, offering unprecedented insights into cardiovascular risks in type 2 diabetes.
Dr. Muyi Aina and Dr. Kelechi Ohiri appointed as CEOs of NPHCDA and NHIA, tasked with ensuring equitable, world-class healthcare for all Nigerians.